Quintaliani G, Reboldi G, Di Napoli A, Nordio M, Limido A, Aucella F, et al. Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology. J Nephrol. 2020;33(4):725–36.
Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90–103.
Boudville N, Kemp A, Clayton P, Lim W, Badve SV, Hawley CM, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol. 2012;23(8):1398–405.
Szeto CC, Li PK. Peritoneal Dialysis-Associated Peritonitis. Clin J Am Soc Nephrol. 2019;14(7):1100–5.
Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley C, et al. Multicenter Registry Analysis of Center Characteristics Associated with technique failure in patients on Incident Peritoneal Dialysis. Clin J Am Soc Nephrol. 2017;12(7):1090–9.
Jagirdar RM, Bozikas A, Zarogiannis SG, Bartosova M, Schmitt CP, Liakopoulos V. Encapsulating peritoneal sclerosis:pathophysiology and current treatment options. Int J Mol Sci. 2019;20(22):5765. Published 2019 November 16.
Burke M, Hawley CM, Badve SV, McDonald SP, Brown FG, Boudville N, et al. Relapsing and recurrent peritoneal dialysis-associated peritonitis: a multicenter registry study. Am J Kidney Dis. 2011;58(3):429–36.
Chung MC, Yu TM, Wu MJ, Chuang YW, Muo CH, Chen CH, et al. Impact of peritoneal dialysis-related peritonitis on PD discontinuation and mortality: a population-based national cohort study. Perit Dial Int. 2022;42(2):194–203.
He P, He LJ, Huang C, Hu JP, Sun SR. Neutrophil-to-lymphocyte ratio and treatment failure in Peritoneal Dialysis-Associated Peritonitis. Front Med (Lausanne). 2021 July;26:8:699502.
Jia L, Li C, Bi X, Wei F, Meng J, Sun G, et al. Prognostic value of systemic Immune-inflammation index among critically ill patients with acute kidney Injury: a retrospective cohort study. J Clin Med. 2022 July;8(14):3978.
Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in Rheumatic diseases. Ann Lab Med. 2019;39(4):345–57.
Zhu M, Chen L, Kong X, Wang X, Li X, Fang Y, et al. The systemic Immune-inflammation index is an independent predictor of survival in breast Cancer patients. Cancer Manag Res. 2022;14:775–820.
Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2003;14(7):1871–9.
Holzer M, Schilcher G, Curcic S, Trieb M, Ljubojevic S, Stojakovic T, et al. Dialysis modalities and HDL composition and function. J Am Soc Nephrol. 2015;26(9):2267–76.
Lin T, Xia X, Yu J, Qiu Y, Yi C, Lin J, et al. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis. Lipids Health Dis. 2020;19(1):51.
Zhan X, Yang M, Zhou R, Wei X, Chen Y, Chen Q. Triglyceride to high-density lipoprotein cholesterol ratio is associated with increased mortality in older patients on peritoneal dialysis. Lipids Health Dis. 2019;18(1):199. Published 2019 November 15.
Li Y, Zhang Y, Lu R, Dai M, Shen M, Zhang J, et al. Lipid metabolism changes in patients with severe COVID-19. Clin Chim Acta. 2021;517:66–73.
Yuan J, Yang YQ, Liu L. Relationship between platelet/lymphocyte ratio and frequent peritoneal dialysis-associated peritonitis in peritoneal dialysis patients[J]. Chin J Nephrol 2021,37(4):327–32.
Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, et al. ISPD Peritonitis recommendations: 2016 update on Prevention and Treatment. Perit Dial Int. 2016;36(5):481–508.
Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y, et al. Peritoneal Dialysis-related infection rates and outcomes: results from the peritoneal Dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis. 2020;76(1):42–53.
Hung SC, Lai YS, Kuo KL, Tarng DC. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J A-m Heart Assoc. 2015;4:e001918.
Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K. Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2015;18:254–62.
Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003;42(5):864–81.
Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis. 2003;41:11–7.
Qiao Yumeng X. Xiao, Dong Jie. Impact of systemic and local inflammation on clinical prognosis after recovery from peritoneal dialysis-associated peritonitis[J]. Chin J Nephrol 2022,38(6):567–71.
Lam MF, Leung JC, Lo WK, Tam S, Chong MC, Lui SL, et al. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis. Nephrol Dial Transpl. 2007;22(5):1445–50.
Bellón T, Martínez V, Lucendo B, del Peso G, Castro MJ, Aroeira LS, et al. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis. Nephrol Dial Transpl. 2011;26(9):2995–3005.
Maraj M, Kuśnierz-Cabala B, Dumnicka P, Gala-Błądzińska A, Gawlik K, Pawlica-Gosiewska D, et al. Malnutrition, inflammation, atherosclerosis syndrome (MIA) and Diet recommendations among End-Stage Renal Disease patients treated with maintenance hemodialysis. Nutrients. 2018;10(1):69.
Jang HR, Rabb H. Immune cells in experimental acute kidney injury. Nat Rev Nephrol. 2015;11(2):88–101.
van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16(3):166–79.
Kertai MD, Zhou S, Karhausen JA, Cooter M, Jooste E, Li YJ, et al. Platelet counts, Acute kidney Injury, and mortality after coronary artery bypass grafting surgery. Anesthesiology. 2016;124(2):339–52.
Tang Y, Zeng X, Feng Y, Chen Q, Liu Z, Luo H, et al. Association of systemic Immune-inflammation index with short-term mortality of congestive heart failure: a retrospective cohort study. Front Cardiovasc Med. 2021;8:753133.
Xu M, Chen R, Liu L, Liu X, Hou J, Liao J, et al. Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: the Dongfeng-Tongji cohort study. Atherosclerosis. 2021;323:20–9.
Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–22.
Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261–72.
Jiang H, Li D, Xu T, Chen Z, Shan Y, Zhao L, et al. Systemic Immune-inflammation index predicts contrast-Induced Acute kidney Injury in patients undergoing coronary angiography: a cross-sectional study. Front Med (Lausanne). 2022;9:841601.
Öztürk ZA, Yesil Y, Kuyumcu ME, Bilici M, Öztürk N, Yeşil NK, et al. Inverse relationship between neutrophil lymphocyte ratio (NLR) and bone mineral density (BMD) in elderly people. Arch Gerontol Geriatr. 2013 Jul-Aug;57(1):81–5.
Lu X, Wang S, Zhang G, Xiong R, Li H. High neutrophil-to-lymphocyte ratio is a significant predictor of Cardiovascular and all-cause mortality in patients undergoing peritoneal Dialysis. Kidney Blood Press Res. 2018;43(2):490–9.
Zhang R, Zhang X, Tang X, Tang L, Shang S, Wang X, et al. The association between diabetes coexisting with low levels of high-density lipoprotein cholesterol and peritoneal dialysis-related peritonitis. Diabetol Metab Syndr. 2022;14(1):60.
Groenen AG, Halmos B, Tall AR, Westerterp M. Cholesterol efflux pathways, inflammation, and atherosclerosis. Crit Rev Biochem Mol Biol. 2021;56(4):426–39.
Raupachova J, Kopecky C, Cohen G. High-density lipoprotein from chronic kidney Disease patients modulates polymorphonuclear leukocytes. Toxins (Basel). 2019;11(2):73.
Tanaka S, Couret D, Tran-Dinh A, Duranteau J, Montravers P, Schwendeman A, et al. High-density lipoproteins during sepsis: from bench to bedside. Crit Care. 2020;24(1):134.
Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol. 2009;4(Suppl 1):49–55.
Liu SH, Li YJ, Wu HH, Lee CC, Lin CY, Weng CH, et al. High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients. PLoS ONE. 2014;9(3):e93063.
Tang Leile G, Xinghua, Li Shaomin. The predictive role of high-density lipoprotein to C-reactive protein ratio on the progression of non-dialysis chronic kidney disease[J]. J Sun Yat-sen Univ (Medical Sciences). 2022;43(2):305–15.
Chow KM, Szeto CC, Leung CB, Kwan BC, Law MC, Li PK. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int. 2005;25(4):374–9.
Meng LF, Yang LM, Zhu XY, Zhang XX, Li XY, Zhao J, et al. Comparison of clinical features and outcomes in peritoneal dialysis-associated peritonitis patients with and without diabetes: a multicenter retrospective cohort study. World J Diabetes. 2020 October;15(10):435–46.
Jung K, Lüthje P, Lundahl J, Brauner A. Low immunogenicity allows Staphylococcus epidermidis to cause PD peritonitis. Perit Dial Int. 2011 Nov-Dec;31(6):672–8.
- The Renal Warrior Project. Join Now
- Source: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-024-03496-z